SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cynthia Villarreal-Garza, Enrique Soto-Perez-de-Celis, Erika Sifuentes, Santiago Ruano, Berenice Baez-Revueltas, Fernando Lara-Medina, Claudia Arce-Salinas, Alberto Alvarado-Miranda, Yanin Chavarri-Guerra, Claudia Caro-Sanchez, Noel Castañeda-Soto, Enrique Bargallo-Rocha, Alejandro Mohar, Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico, The Breast, 2015, 24, 3, 218

    CrossRef

  2. 2
    J. R. Tichy, A. M. Deal, C. K. Anders, K. Reeder-Hayes, L. A. Carey, Race, response to chemotherapy, and outcome within clinical breast cancer subtypes, Breast Cancer Research and Treatment, 2015, 150, 3, 667

    CrossRef

  3. 3
    Abenaa M Brewster, Mariana Chavez-MacGregor, Powel Brown, Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry, The Lancet Oncology, 2014, 15, 13, e625

    CrossRef

  4. 4
    Kunpeng Wu, Qiaozhu Yang, Yi Liu, Aibing Wu, Zhixiong Yang, Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy, World Journal of Surgical Oncology, 2014, 12, 1, 95

    CrossRef

  5. 5
    M Loh, D Chua, Y Yao, R A Soo, K Garrett, N Zeps, C Platell, T Minamoto, K Kawakami, B Iacopetta, R Soong, Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?, The Pharmacogenomics Journal, 2013, 13, 5, 423

    CrossRef

  6. 6
    Qian Wang-Lopez, Catherine Abrial, Eloïse Planchat, Marie-Ange Mouret-Reynier, Hervé Cure, Pierre Gimbergues, Pascale Dubray-Longeras, Emilie Gadea, Fabrice Kwiatkowski, Frédérique Penault-Llorca, Philippe Chollet, Xavier Durando, Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer, The Breast Journal, 2013, 19, 4
  7. 7
    Mariana Chavez-MacGregor, Christina A. Clarke, Daphne Lichtensztajn, Gabriel N. Hortobagyi, Sharon H. Giordano, Male breast cancer according to tumor subtype and race , Cancer, 2013, 119, 9
  8. You have free access to this content8
    Jean L. Wright, Cristiane Takita, Isildinha M. Reis, Wei Zhao, Kunal Saigal, Aaron Wolfson, Arnold Markoe, Mecker Moller, Judith Hurley, Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation, Cancer, 2013, 119, 1
  9. 9
    Nehmat Houssami, Petra Macaskill, Gunter von Minckwitz, Michael L. Marinovich, Eleftherios Mamounas, Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy, European Journal of Cancer, 2012, 48, 18, 3342

    CrossRef

  10. 10
    H E Lee, J H Kim, Y J Kim, S Y Choi, S-W Kim, E Kang, I Y Chung, I A Kim, E J Kim, Y Choi, H S Ryu, S Y Park, An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer, British Journal of Cancer, 2011, 104, 11, 1730

    CrossRef

  11. 11
    W.M. Sikov, Pathologic Complete Response in Breast Cancer Patients Receiving Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy: Evaluating the Effect of Race/Ethnicity, Breast Diseases: A Year Book Quarterly, 2011, 22, 3, 318

    CrossRef

  12. 12
    W.M. Sikov, Pathologic Complete Response in Breast Cancer Patients Receiving Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy: Evaluating the Effect of Race/Ethnicity, Yearbook of Oncology, 2011, 2011, 23

    CrossRef

  13. 13
    Maxine Sun, Firas Abdollah, Daniel Liberman, Al'a Abdo, Rodolphe Thuret, Zhe Tian, Shahrokh F. Shariat, Francesco Montorsi, Paul Perrotte, Pierre I. Karakiewicz, Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors, Cancer, 2011, 117, 18
  14. 14
    R C Fields, V E Strong, M Gönen, K A Goodman, N P Rizk, D P Kelsen, D H Ilson, L H Tang, M F Brennan, D G Coit, M A Shah, Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma, British Journal of Cancer, 2011, 104, 12, 1840

    CrossRef